Pet Diabetes Care Devices Market Report 2025

The pet diabetes care devices market size has grown strongly in recent years. It will grow from $2.56 billion in 2024 to $2.74 billion in 2025 at a compound annual growth rate (CAGR) of 7%. The growth in the historic period can be attributed to introduction of glucose monitoring devices, increase in pet diabetes cases, improvement in treatment outcomes, rise in pet healthcare expenditure, education and veterinary support.

The pet diabetes care devices market size is expected to see strong growth in the next few years. It will grow to $3.91 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to rise in pet health awareness, adoption of connected devices, personalized treatment solutions, telehealth expansion, research and development investments. Major trends in the forecast period include collaboration and partnerships, innovations in insulin delivery, education and awareness, telemedicine and remote veterinary care, personalized and targeted treatment.

The anticipated rise in pet health expenditure is set to drive the growth of the pet diabetes care device market in the foreseeable future. Pet health expenditure encompasses the financial resources dedicated by pet owners to address their pets' health concerns, including veterinary care, equipment, and necessary healthcare devices. Notably, according to data from the American Veterinary Medical Association released in October 2022, consumer spending on dogs and cats has shown a consistent increase. Yearly veterinarian visit expenditures for households with one dog rose from $224 in 2020 to $362 in 2022. Similarly, average annual expenditures on veterinarian visits for homes with cats increased from $189 in 2020 to $321 in 2022. This upward trend in pet health expenditure is a driving force behind the growth of the pet diabetes care device market.

The growing trend of pet ownership is expected to fuel the expansion of the pet diabetes care device market in the coming years. Pet ownership involves a range of responsibilities, including providing food, water, shelter, physical exercise, and healthcare for domesticated animals such as dogs, cats, fish, birds, and others. Pet diabetes care devices play a crucial role in ensuring the well-being of diabetic pets by facilitating accurate monitoring, precise treatment, and effective communication between pet owners and veterinary professionals. According to data from the World Animal Foundation in October 2023, dog ownership is more prevalent, with 65.1 million dogs compared to 46.5 million cats. Additionally, 11 million households own saltwater fish tanks, surpassing the 2.2 million horses owned by horse owners. The increasing prevalence of pet ownership is thus a significant factor propelling the pet diabetes care device market.

A prominent trend in the pet diabetes care device market is the integration of technological advancements. Major companies in this market are actively developing innovative technologies to enhance their market positions. For instance, Zoetis Inc., a US-based veterinary pharmaceutical company, introduced the AlphaTrak 3 blood glucose monitoring system in February 2023. This system, designed for cats and dogs in the United States, features a new mobile app that enables pet owners and veterinary professionals to collect, store, and share data seamlessly. The app facilitates quick sharing of a pet's glucose levels and other essential details in real time, fostering increased confidence in diabetic pet care. The AlphaTrak 3 device delivers accurate information in as little as five seconds, utilizing only 0.3 microliters of blood and providing a blood sugar dynamic ranging from 20 to 750 milligrams per deciliter. The incorporation of advanced technology, including improved data capture from pet owners, underscores the industry's commitment to advancing diabetic pet care.

Major companies operating in the pet diabetes care devices market are adopting a strategic partnership approach to enhance their capabilities. Strategic partnerships involve leveraging the strengths and resources of collaborating companies to achieve mutual benefits and success. An illustrative example is the co-branded distribution agreement between ALR Technologies SG Ltd., a Singapore-based medical device company, and Covetrus Inc., announced in December 2022. This agreement concerns ALRT's continuous glucose monitoring device for diabetic dogs and cats, known as the GluCurve Pet CGM. Covetrus gains exclusive rights to offer GluCurve Pet CGM as a co-branded device to veterinary clinics in several countries worldwide, including the United States, Brazil, the United Kingdom, and the European Union. This strategic partnership aims to make continuous blood sugar monitoring more accessible to veterinarians and underscores the collaborative efforts within the pet diabetes care device market.

In September 2022, Zoetis, a US-based pet medicine vaccinations manufacturer, acquired NewMetrica for an undisclosed amount. This acquisition positions Zoetis to leverage NewMetrica's algorithms for earlier disease identification and treatment, enhancing their understanding of pet quality of life and becoming a crucial element in future product development. NewMetrica, a UK-based company specializing in pet diabetes care devices, becomes an integral part of Zoetis' strategic growth initiatives in the sector.

Major companies operating in the pet diabetes care devices market include Allison Medical Inc., Zoetis Inc., Becton Dickinson and Company, Boehringer Ingelheim Vetmedica Inc., Henry Schein Animal Health, Apotex Inc., Merck Co. Inc., Trividia Health Inc., UltiMed Inc., ACON Laboratories Inc., i-SENS Inc., TaiDoc Technology Corporation, Abbott Laboratories, Novo Nordisk AS, Covetrus AG, Eli Lilly and Company, Bayer AG, Terumo Corporation, AccuBioTech Co. Ltd., ALR Technologies Inc.

North America was the largest region in the pet diabetes care devices market in 2024. The regions covered in the pet diabetes care devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pet diabetes care devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Pet diabetes care devices are medical tools designed to manage diabetes in pets through routine check-ups, blood and urine testing, and observation of the animal's weight, appetite, drinking, and urination. These devices play a crucial role in controlling the blood sugar levels of diabetic pets, preventing dangerously high or low levels to ensure their well-being.

The main animal types addressed by pet diabetes care devices include dogs, cats, and horses. Dogs, as four-legged companions commonly kept as pets or used for various purposes, benefit from these devices for monitoring their health when dealing with diabetes. The key devices in this category include glucose monitoring devices and insulin delivery devices. These devices are utilized by various stakeholders, including pet owners for homecare purposes, veterinary hospitals, and other healthcare providers involved in managing diabetes in pets.

The pet diabetes care devices market research report is one of a series of new reports that provides pet diabetes care devices market statistics, including global market size, regional shares, competitors with a pet diabetes care devices market share, detailed pet diabetes care devices market segments, market trends and opportunities, and any further data you may need to thrive in the pet diabetes care devices industry. This pet diabetes care devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pet diabetes care device market consists of sales of insulin delivery devices, insulin delivery pen amd insulin syringes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.